We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why JPM, BAC, C, WFC and Other Bank Stocks are Soaring
Read MoreHide Full Article
The week begun with a sense of optimism as the coronavirus vaccine hope added to Joe Biden winning the U.S. Presidential election.
The vaccine being developed by Pfizer Inc. (PFE - Free Report) and BioNTech SE has been found to be more than 90% effective in preventing coronavirus infections. This is the source of investors’ bullish stance. Thus, all three major indexes – the S&P 500, Dow Jones and Nasdaq – hit all-time highs. While both S&P 500 and Dow Jones ended yesterday in green, the tech-driven Nasdaq fell 1.5%.
The S&P 500 Financials sector was one of the top performers, rallying 8.2%. Further, SPDR S&P Regional Banking ETF and KBW Nasdaq Bank Index jumped 15.4% and 13.5%, respectively.
The Wall Street biggies – JPMorgan (JPM - Free Report) surged 13.5%, Bank of America (BAC - Free Report) 14.2%, Citigroup (C - Free Report) 11.5% and Wells Fargo (WFC - Free Report) were up 10.5%. In fact, all the bank stocks on the S&P 500 Index were up more than 5%. Moreover, several other smaller banks including Prosperity Bancshares (PB - Free Report) , BancorpSouth Bank, Webster Financial Corporation (WBS - Free Report) , Associated Banc-Corp and New York Community Bancorp rallied substantially.
Why Vaccine-Related Development is Propelling Bank Stocks
Bank stocks have been among the worst performing industry since the coronavirus outbreak in March. This is mainly due to the fact that banks’ financials are highly dependent on the health of the economy.
With the pandemic impeding business activities across the globe and resulting in economic slowdown, banks have been hit hard. This, coupled with low interest rates, (the Federal Reserve cut the rates to near-zero in mid-March to support the U.S. economy) has been weighing significantly on the bank stocks.
Therefore, a positive development related to coronavirus vaccine is being seen as a hope for restoration of normal activities. Also, it indicates that there is a high chance that other vaccine developers could find favorable results soon. If these happen, economic recovery will likely speed up and the chances of banks facing high level of delinquent loans will lessen. This will also reduce loan-loss uncertainty, which had led banks to built billion of dollars of reserves.
Further, as the economy recovers, demand for loan (which had been faltering of late due to less appetite among businesses to grow) should rise. This will, in turn support banks’ net interest income (its primary source of revenues) and net interest margin despite low rate environment.
Additionally, several banks had voluntarily/involuntarily suspended share buybacks and even slashed dividends to conserve liquidity. Thus, with the economic recovery, banks’ capital development actions are expected to return to pre-crisis level. This will enhance shareholder value.
Though the vaccine-related development is good news, banks are not expected to be out of woods just yet. Distribution of the vaccine to those who immediately need it and to the larger population will take time.
But one should keep an eye on fundamentally strong bank stocks and make wise investment decisions till then to get profitable returns in the future.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
Image: Bigstock
Here's Why JPM, BAC, C, WFC and Other Bank Stocks are Soaring
The week begun with a sense of optimism as the coronavirus vaccine hope added to Joe Biden winning the U.S. Presidential election.
The vaccine being developed by Pfizer Inc. (PFE - Free Report) and BioNTech SE has been found to be more than 90% effective in preventing coronavirus infections. This is the source of investors’ bullish stance. Thus, all three major indexes – the S&P 500, Dow Jones and Nasdaq – hit all-time highs. While both S&P 500 and Dow Jones ended yesterday in green, the tech-driven Nasdaq fell 1.5%.
The S&P 500 Financials sector was one of the top performers, rallying 8.2%. Further, SPDR S&P Regional Banking ETF and KBW Nasdaq Bank Index jumped 15.4% and 13.5%, respectively.
The Wall Street biggies – JPMorgan (JPM - Free Report) surged 13.5%, Bank of America (BAC - Free Report) 14.2%, Citigroup (C - Free Report) 11.5% and Wells Fargo (WFC - Free Report) were up 10.5%. In fact, all the bank stocks on the S&P 500 Index were up more than 5%. Moreover, several other smaller banks including Prosperity Bancshares (PB - Free Report) , BancorpSouth Bank, Webster Financial Corporation (WBS - Free Report) , Associated Banc-Corp and New York Community Bancorp rallied substantially.
Why Vaccine-Related Development is Propelling Bank Stocks
Bank stocks have been among the worst performing industry since the coronavirus outbreak in March. This is mainly due to the fact that banks’ financials are highly dependent on the health of the economy.
With the pandemic impeding business activities across the globe and resulting in economic slowdown, banks have been hit hard. This, coupled with low interest rates, (the Federal Reserve cut the rates to near-zero in mid-March to support the U.S. economy) has been weighing significantly on the bank stocks.
Therefore, a positive development related to coronavirus vaccine is being seen as a hope for restoration of normal activities. Also, it indicates that there is a high chance that other vaccine developers could find favorable results soon. If these happen, economic recovery will likely speed up and the chances of banks facing high level of delinquent loans will lessen. This will also reduce loan-loss uncertainty, which had led banks to built billion of dollars of reserves.
Further, as the economy recovers, demand for loan (which had been faltering of late due to less appetite among businesses to grow) should rise. This will, in turn support banks’ net interest income (its primary source of revenues) and net interest margin despite low rate environment.
Additionally, several banks had voluntarily/involuntarily suspended share buybacks and even slashed dividends to conserve liquidity. Thus, with the economic recovery, banks’ capital development actions are expected to return to pre-crisis level. This will enhance shareholder value.
Though the vaccine-related development is good news, banks are not expected to be out of woods just yet. Distribution of the vaccine to those who immediately need it and to the larger population will take time.
But one should keep an eye on fundamentally strong bank stocks and make wise investment decisions till then to get profitable returns in the future.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>